Dose-dependent transitions in mechanisms of toxicity.

[1]  D. Krewski,et al.  Toxicological Risk Assessment , 2019 .

[2]  Melvin E Andersen,et al.  Dose-dependent transitions in mechanisms of toxicity: case studies. , 2004, Toxicology and applied pharmacology.

[3]  S. Goldhaber,et al.  Trace element risk assessment: essentiality vs. toxicity. , 2003, Regulatory toxicology and pharmacology : RTP.

[4]  Jan Alexander,et al.  Risk analysis applied to food fortification , 2003, Public Health Nutrition.

[5]  Patrick Poulin,et al.  Utility of physiologically based pharmacokinetic models to drug development and rational drug discovery candidate selection. , 2003, Toxicology letters.

[6]  G. Ladics,et al.  Evaluation of a 15-day screening assay using intact male rats for identifying antiandrogens. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[7]  Gregory S Ladics,et al.  Evaluation of a 15-day screening assay using intact male rats for identifying steroid biosynthesis inhibitors and thyroid modulators. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[8]  L. Deftos,et al.  Many Courts Still Frye Scientific Evidence , 2002, Science.

[9]  David L. Faigman.  Is Science Different for Lawyers? , 2002, Science.

[10]  N. Kernohan,et al.  Direct comparison of the nature of mouse and human GST T1-1 and the implications on dichloromethane carcinogenicity. , 2002, Toxicology and applied pharmacology.

[11]  Harvey J Clewell,et al.  A consistent approach for the application of pharmacokinetic modeling in cancer and noncancer risk assessment. , 2001, Environmental health perspectives.

[12]  J. Ashby.  Increasing the sensitivity of the rodent uterotrophic assay to estrogens, with particular reference to bisphenol A. , 2001, Environmental health perspectives.

[13]  M Younes,et al.  IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. , 2001, Regulatory toxicology and pharmacology : RTP.

[14]  G. Johanson,et al.  A Bayesian analysis of the influence of GSTT1 polymorphism on the cancer risk estimate for dichloromethane. , 2001, Toxicology and applied pharmacology.

[15]  F. Gonzalez,et al.  Understanding the role of xenobiotic-metabolism in chemical carcinogenesis using gene knockout mice. , 2001, Mutation research.

[16]  K Walton,et al.  Default Factors for Interspecies Differences in the Major Routes of Xenobiotic Elimination , 2001 .

[17]  I. Rusyn,et al.  Expression of base excision repair enzymes in rat and mouse liver is induced by peroxisome proliferators and is dependent upon carcinogenic potency. , 2000, Carcinogenesis.

[18]  A. Hendrickx,et al.  Vitamin A teratogenicity and risk assessment in the macaque retinoid model. , 2000, Reproductive toxicology.

[19]  F Y Bois,et al.  Statistical analysis of Fisher et al. PBPK model of trichloroethylene kinetics. , 2000, Environmental health perspectives.

[20]  R. Weaver,et al.  Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man , 2000, Xenobiotica; the fate of foreign compounds in biological systems.

[21]  J. Shaddock,et al.  Detoxification of carcinogenic aromatic and heterocyclic amines by enzymatic reduction of the N-hydroxy derivative. , 1999, Cancer letters.

[22]  C J Portier,et al.  Effects of glutathione transferase theta polymorphism on the risk estimates of dichloromethane to humans. , 1999, Toxicology and applied pharmacology.

[23]  K. Crofton,et al.  Screening methods for thyroid hormone disruptors. , 1999, Environmental health perspectives.

[24]  M. Andersen,et al.  Pharmacokinetic data needs to support risk assessments for inhaled and ingested manganese. , 1999, Neurotoxicology.

[25]  E J Calabrese,et al.  Hormesis: A Highly Generalizable and Reproducible Phenomenon With Important Implications for Risk Assessment , 1999, Risk analysis : an official publication of the Society for Risk Analysis.

[26]  K. Krishnan,et al.  Molecular Structure-Based Prediction of the Toxicokinetics of Inhaled Vapors in Humans , 1999 .

[27]  K T Bogen,et al.  Mechanistic model predicts a U-shaped relation of radon exposure to lung cancer risk reflected in combined occupational and US residential data , 1998, Human & experimental toxicology.

[28]  M E Andersen,et al.  Mechanistic modeling of rodent liver tumor promotion at low levels of exposure: an example related to dose-response relationships for 2,3,7,8-tetrachlorodibenzo-p-dioxin , 1998, Human & experimental toxicology.

[29]  T. Brüning,et al.  Species differences in the glutathione transferase GSTT1-1 activity towards the model substrates methyl chloride and dichloromethane in liver and kidney , 1998, Archives of Toxicology.

[30]  H. Yamazaki,et al.  Activation and detoxication of aflatoxin B1. , 1998, Mutation research.

[31]  T. Shimada,et al.  Activation of procarcinogens by human cytochrome P450 enzymes. , 1998, Mutation research.

[32]  J. Magdalou,et al.  Effect of cigarette smoke on UDP-glucuronosyltransferase activity and cytochrome P450 content in liver, lung and kidney microsomes in mice. , 1998, Pharmacology & toxicology.

[33]  M C Kohn,et al.  The importance of anatomical realism for validation of physiological models of disposition of inhaled toxicants. , 1997, Toxicology and applied pharmacology.

[34]  D J Rance,et al.  The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data. , 1997, The Journal of pharmacology and experimental therapeutics.

[35]  G M Pastino,et al.  A comparison of physiologically based pharmacokinetic model predictions and experimental data for inhaled ethanol in male and female B6C3F1 mice, F344 rats, and humans. , 1997, Toxicology and applied pharmacology.

[36]  J. A. Bond,et al.  Physiologically based pharmacokinetic modeling of 1,3-butadiene, 1,2-epoxy-3-butene, and 1,2:3,4-diepoxybutane toxicokinetics in mice and rats. , 1997, Carcinogenesis.

[37]  K. Wirkner,et al.  Effect of long-term ethanol pretreatment on the metabolism of dichloromethane to carbon monoxide in rats. , 1997, Toxicology and applied pharmacology.

[38]  B. Ballantyne,et al.  Pharmacokinetics of ethylene glycol. II. Tissue distribution, dose-dependent elimination, and identification of urinary metabolites following single intravenous, peroral or percutaneous doses in female Sprague-Dawley rats and CD-1 mice. , 1996, Xenobiotica; the fate of foreign compounds in biological systems.

[39]  G. L. Kedderis,et al.  Prediction of furan pharmacokinetics from hepatocyte studies: comparison of bioactivation and hepatic dosimetry in rats, mice, and humans. , 1996, Toxicology and applied pharmacology.

[40]  J. Swenberg,et al.  DNA adducts: biological markers of exposure and potential applications to risk assessment. , 1996, Mutation research.

[41]  B. Ballantyne,et al.  Pharmacokinetics of ethylene glycol. I. Plasma disposition after single intravenous, peroral, or percutaneous doses in female Sprague-Dawley rats and CD-1 mice. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[42]  B. Ballantyne,et al.  Pharmacokinetics of ethylene glycol. III. Plasma disposition and metabolic fate after single increasing intravenous, peroral, or percutaneous doses in the male Sprague-Dawley rat. , 1996, Xenobiotica; the fate of foreign compounds in biological systems.

[43]  Mitchell J. Small,et al.  Updating Uncertainty in an Integrated Risk Assessment: Conceptual Framework and Methods , 1995 .

[44]  L. Anderson,et al.  Dosimetry of O6-methylguanine in rat DNA after low-dose, chronic exposure to N-nitrosodimethylamine (NDMA). Implications for the mechanism of NDMA hepatocarcinogenesis. , 1995, Carcinogenesis.

[45]  H. Yamazaki,et al.  Oxidation of aflatoxin B1 by bacterial recombinant human cytochrome P450 enzymes. , 1995, Chemical research in toxicology.

[46]  E. Carney.  An integrated perspective on the developmental toxicity of ethylene glycol. , 1994, Reproductive toxicology.

[47]  M E Andersen,et al.  A physiologically based pharmacokinetic model for 2,3,7,8-tetrabromodibenzo-p-dioxin (TBDD) in the rat: tissue distribution and CYP1A induction. , 1993, Toxicology and applied pharmacology.

[48]  R H Reitz,et al.  Dose-dependent metabolism and dose setting in chronic studies. , 1992, Toxicology letters.

[49]  W Leisenring,et al.  Statistical properties of the NOAEL. , 1992, Regulatory toxicology and pharmacology : RTP.

[50]  G. Iliakis,et al.  Kinetics of DNA double-strand break repair throughout the cell cycle as assayed by pulsed field gel electrophoresis in CHO cells. , 1991, International journal of radiation biology.

[51]  M. S. Wells,et al.  Hematotoxicity and concentration-dependent conjugation of phenol in mice following inhalation exposure to benzene. , 1991, Toxicology letters.

[52]  K. Wheeler,et al.  Saturation of DNA repair measured by alkaline elution. , 1991, Radiation research.

[53]  D Hattis,et al.  Pharmacokinetic principles for dose-rate extrapolation of carcinogenic risk from genetically active agents. , 1990, Risk analysis : an official publication of the Society for Risk Analysis.

[54]  D Krewski,et al.  Carcinogenic risk assessment with time-dependent exposure patterns. , 1988, Risk analysis : an official publication of the Society for Risk Analysis.

[55]  J F Bithell,et al.  A new calculation of the carcinogenic risk of obstetric X-raying. , 1988, Statistics in medicine.

[56]  P. Working,et al.  Degeneration and regeneration of the olfactory epithelium following inhalation exposure to methyl bromide: pathology, cell kinetics, and olfactory function. , 1988, Toxicology and applied pharmacology.

[57]  S. Belinsky,et al.  Molecular dosimetry of DNA adduct formation and cell toxicity in rat nasal mucosa following exposure to the tobacco specific nitrosamine 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone and their relationship to induction of neoplasia. , 1987, Cancer research.

[58]  I. Radford.  Effect of cell-cycle position and dose on the kinetics of DNA double-strand breakage repair in X-irradiated Chinese hamster cells. , 1987, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[59]  Hattis.  Pharmacokinetic/mechanism-based analysis of the carcinogenic risk of ethylene oxide , 1987 .

[60]  D. Kaden,et al.  Killing and mutation of human lymphoblast cells by aflatoxin B1: evidence for an inducible repair response. , 1987, Cancer research.

[61]  H. Pylypiw,et al.  Pharmacokinetics of N-nitrosodimethylamine in beagles. , 1987, Cancer research.

[62]  K. McMartin,et al.  Methanol and Ethylene Glycol Poisonings , 1986, Medical toxicology.

[63]  H J Clewell,et al.  Metabolism of inhaled dihalomethanes in vivo: differentiation of kinetic constants for two independent pathways. , 1986, Toxicology and applied pharmacology.

[64]  A. Chamberlain.  Prediction of response of blood lead to airborne and dietary lead from volunteer experiments with lead isotopes , 1985, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[65]  J. Swenberg,et al.  Differential repair of O4-alkylthymidine following exposure to methylating and ethylating hepatocarcinogens. , 1985, Carcinogenesis.

[66]  K S Crump,et al.  A new method for determining allowable daily intakes. , 1984, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[67]  D. Murray,et al.  The efficiency of DNA strand-break repair in two fibrosarcoma tumors and in normal tissues of mice irradiated in vivo with X rays. , 1984, Radiation research.

[68]  K. Wheeler,et al.  DNA accessibility: a determinant of mammalian cell differentiation? , 1983, Radiation research.

[69]  T. C. Marshall.  Dose-dependent disposition of ethylene glycol in the rat after intravenous administration. , 1982, Journal of toxicology and environmental health.

[70]  Y. Alarie.  Dose-response analysis in animal studies: prediction of human responses. , 1981, Environmental health perspectives.

[71]  P. Desilva.  Determination of lead in plasma and studies on its relationship to lead in erythrocytes. , 1981, British journal of industrial medicine.

[72]  G. W. Morgan,et al.  Kinetic Data Analysis, Design and Analysis of Enzyme and Pharmacokinetic Experiments , 1981 .

[73]  J A Swenberg,et al.  Induction of squamous cell carcinomas of the rat nasal cavity by inhalation exposure to formaldehyde vapor. , 1980, Cancer research.

[74]  P. Watanabe,et al.  Risk of angiosarcoma in workers exposed to vinyl chloride as predicted from studies in rats. , 1979, Toxicology and applied pharmacology.

[75]  A. Pegg,et al.  Formation and subsequent removal of O6-methylguanine from deoxyribonucleic acid in rat liver and kidney after small doses of dimethylnitrosamine. , 1978, The Biochemical journal.

[76]  C. Maltoni,et al.  CARCINOGENICITY BIOASSAYS OF VINYL CHLORIDE: CURRENT RESULTS , 1975, Annals of the New York Academy of Sciences.

[77]  C. Klaassen,et al.  Biliary excretion of manganese in rats, rabbits, and dogs. , 1974, Toxicology and applied pharmacology.

[78]  B B Brodie,et al.  Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. , 1973, The Journal of pharmacology and experimental therapeutics.

[79]  B B Brodie,et al.  Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. , 1973, The Journal of pharmacology and experimental therapeutics.

[80]  I. N. Sneddon,et al.  The Mathematical Approach to Physiological Problems , 1972, The Mathematical Gazette.

[81]  G C Cotzias,et al.  Chronic manganese poisoning Clearance of tissue manganese concentrations with persistence of the neurological picture , 1968, Neurology.

[82]  D. Evans,et al.  HUMAN ACETYLATION POLYMORPHISM. , 1964, The Journal of laboratory and clinical medicine.

[83]  E. Underwood.  Trace Elements in Human and Animal Nutrition , 1956, Agronomy Journal.

[84]  Gunnar Johanson,et al.  A physiologically based pharmacokinetic model for butadiene and its metabolite butadiene monoxide in rat and mouse and its significance for risk extrapolation , 2005, Archives of Toxicology.

[85]  Gunnar F. Nordberg,et al.  Principles and Methods for the Assessment of Risk from Essential Trace Elements , 2002 .

[86]  B. Stenerlöw,et al.  Rejoining of DNA fragments produced by radiations of different linear energy transfer. , 2000, International journal of radiation biology.

[87]  H. Yamazaki,et al.  Cytochrome P450-dependent drug oxidation activities in liver microsomes of various animal species including rats, guinea pigs, dogs, monkeys, and humans , 1997, Archives of Toxicology.

[88]  J A Foran,et al.  Principles for the Selection of Doses in Chronic Rodent Bioassays , 1997 .

[89]  T. Fennell,et al.  In vivo and in vitro kinetics of ethylene oxide metabolism in rats and mice. , 1996, Toxicology and applied pharmacology.

[90]  W. Dekant,et al.  Bioactivation of xenobiotics by formation of toxic glutathione conjugates. , 1991, Chemico-biological interactions.

[91]  F. Russel,et al.  Saturable Pharmacokinetics in the Renal Excretion of Drugs , 1989, Clinical pharmacokinetics.

[92]  C. Klaassen,et al.  Acetaminophen decreases adenosine 3'-phosphate 5'-phosphosulfate and uridine diphosphoglucuronic acid in rat liver. , 1985, Drug metabolism and disposition: the biological fate of chemicals.

[93]  D. Liebler,et al.  Enzymatic activation of chemicals to toxic metabolites. , 1985, Critical reviews in toxicology.

[94]  J. Gillette.  Problems in risk assessment , 1982 .

[95]  M. Juchau.  The Biochemical basis of chemical teratogenesis , 1981 .

[96]  L. Endrenyi.  Design of Experiments for Estimating Enzyme and Pharmacokinetic Parameters , 1981 .